VivoSim Labs, Inc. (VIVS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.24 (-6.14%), Market cap $0.00B, P/E ratio 0.72, 52-week low–high $1.27 ~ $4.78.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech co
Financial statements, price targets, institutional (13F) holdings and related news for VivoSim Labs, Inc. are updated in real time on BlackAll Trade.
VivoSim Labs, Inc. trades at $0.24 (-6.14%). Real-time quotes and charts are available on BlackAll Trade.
VivoSim Labs, Inc. has a market cap of about $0.00B. Its P/E ratio is 0.72.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers p